These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 10941138)

  • 21. Characterization of radioiodinated (-)-ortho-iodovesamicol binding in rat brain preparations.
    Shiba K; Yano T; Sato W; Mori H; Tonami N
    Life Sci; 2002 Aug; 71(13):1591-8. PubMed ID: 12127913
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological characterization of the vesamicol analogue (+)-[(125)I]MIBT in primate brain.
    Staley JK; Mash DC; Parsons SM; Khare AB; Efange SM
    Eur J Pharmacol; 1997 Nov; 338(2):159-69. PubMed ID: 9455998
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Imaging of cholinergic terminals using the radiotracer [18F](+)-4-fluorobenzyltrozamicol: in vitro binding studies and positron emission tomography studies in nonhuman primates.
    Mach RH; Voytko ML; Ehrenkaufer RL; Nader MA; Tobin JR; Efange SM; Parsons SM; Gage HD; Smith CR; Morton TE
    Synapse; 1997 Apr; 25(4):368-80. PubMed ID: 9097396
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brain vesicular acetylcholine transporter in human users of drugs of abuse.
    Siegal D; Erickson J; Varoqui H; Ang L; Kalasinsky KS; Peretti FJ; Aiken SS; Wickham DJ; Kish SJ
    Synapse; 2004 Jun; 52(4):223-32. PubMed ID: 15103689
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New transport assay demonstrates vesicular acetylcholine transporter has many alternative substrates.
    Bravo DT; Kolmakova NG; Parsons SM
    Neurochem Int; 2005 Sep; 47(4):243-7. PubMed ID: 15979764
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Syntheses and in vitro evaluation of decalinvesamicol analogues as potential imaging probes for vesicular acetylcholine transporter (VAChT).
    Kozaka T; Uno I; Kitamura Y; Miwa D; Ogawa K; Shiba K
    Bioorg Med Chem; 2012 Aug; 20(16):4936-41. PubMed ID: 22831799
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological characterization of N,N-dimethyl-2-(2-amino-4-methylphenyl thio)benzylamine as a ligand of the serotonin transporter with high affinity and selectivity.
    Chalon S; Tarkiainen J; Garreau L; Hall H; Emond P; Vercouillie J; Farde L; Dasse P; Varnas K; Besnard JC; Halldin C; Guilloteau D
    J Pharmacol Exp Ther; 2003 Jan; 304(1):81-7. PubMed ID: 12490578
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cholinergic activity of aged rhesus monkeys revealed by positron emission tomography.
    Voytko ML; Mach RH; Gage HD; Ehrenkaufer RL; Efange SM; Tobin JR
    Synapse; 2001 Jan; 39(1):95-100. PubMed ID: 11071714
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regional brain imaging of vesicular acetylcholine transporter using o-[125 I]iodo-trans-decalinvesamicol as a new potential imaging probe.
    Kozaka T; Uno I; Kitamura Y; Miwa D; Anwar-Ul Azim M; Ogawa K; Shiba K
    Synapse; 2014 Mar; 68(3):107-13. PubMed ID: 24174343
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and evaluation of a new vesamicol analog o-[(11)C]methyl-trans-decalinvesamicol as a PET ligand for the vesicular acetylcholine transporter.
    Kitamura Y; Kozaka T; Miwa D; Uno I; Azim MA; Ogawa K; Taki J; Kinuya S; Shiba K
    Ann Nucl Med; 2016 Feb; 30(2):122-9. PubMed ID: 26608176
    [TBL] [Abstract][Full Text] [Related]  

  • 31. (+)-p-([18F]fluorobenzyl)spirotrozamicol [(+)-[18F]spiro-FBT]: synthesis and biological evaluation of a high-affinity ligand for the vesicular acetylcholine transporter (VAChT).
    Efange SM; Nader MA; Ehrenkaufer RL; Khare AB; Smith CR; Morton TE; Mach RH
    Nucl Med Biol; 1999 Feb; 26(2):189-92. PubMed ID: 10100218
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutational and pH analysis of ionic residues in transmembrane domains of vesicular acetylcholine transporter.
    Bravo DT; Kolmakova NG; Parsons SM
    Biochemistry; 2005 Jun; 44(22):7955-66. PubMed ID: 15924414
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nerve growth factor increases the synthesis and release of acetylcholine and the expression of vesicular acetylcholine transporter in primary cultured rat embryonic septal cells.
    Oosawa H; Fujii T; Kawashima K
    J Neurosci Res; 1999 Aug; 57(3):381-7. PubMed ID: 10412029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Halogenated 4-(phenoxymethyl)piperidines as potential radiolabeled probes for sigma-1 receptors: in vivo evaluation of [123I]-1-(iodopropen-2-yl)-4-[(4-cyanophenoxy)methyl]pip eri dine.
    Waterhouse RN; Mardon K; Giles KM; Collier TL; O'Brien JC
    J Med Chem; 1997 May; 40(11):1657-67. PubMed ID: 9171875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of retinoic acid and of cyclic AMP on the expression of choline acetyltransferase and of vesicular acetylcholine transporter in NG108-15 cells.
    Diebler MF; Tomasi M; Meunier FM; Israël M; Dolezal V
    J Physiol Paris; 1998; 92(5-6):379-84. PubMed ID: 9789841
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of noninvasive quantification methods of in vivo vesicular acetylcholine transporter using [123I]-IBVM SPECT imaging.
    Barret O; Mazère J; Seibyl J; Allard M
    J Cereb Blood Flow Metab; 2008 Sep; 28(9):1624-34. PubMed ID: 18506194
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo imaging of the vesicular acetylcholine transporter and the vesicular monoamine transporter.
    Efange SM
    FASEB J; 2000 Dec; 14(15):2401-13. PubMed ID: 11099458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro characterization of radioiodinated (+)-2-[4-(4-iodophenyl) piperidino]cyclohexanol [(+)-pIV] as a sigma-1 receptor ligand.
    Shiba K; Ogawa K; Mori H
    Bioorg Med Chem; 2005 Feb; 13(4):1095-9. PubMed ID: 15670917
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and in vitro evaluation of N-substituted aza-trozamicol analogs as vesicular acetylcholine transporter ligands.
    Assaad T; Mavel S; Parsons SM; Kruse S; Galineau L; Allouchi H; Kassiou M; Chalon S; Guilloteau D; Emond P
    Bioorg Med Chem Lett; 2006 May; 16(10):2654-7. PubMed ID: 16516472
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vesicular neurotransmitter transporters in Huntington's disease: initial observations and comparison with traditional synaptic markers.
    Suzuki M; Desmond TJ; Albin RL; Frey KA
    Synapse; 2001 Sep; 41(4):329-36. PubMed ID: 11494403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.